Quillichew Er Tablet, Chewable, Extended Release
Product Images NDC 24478-076

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Quillichew Er (NDC 24478-076). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nextwave Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quillichew Er 1

FDA Label Image

Quillichew Er 2

FDA Label Image

Quillichew Er 3

This appears to be a table showing LS Mean SKAMP-Combined Score (+SE) for a placebo group and a group taking QuiliChew ER at different post-dose hours. The table has limited information, but it suggests that QuilChew ER may result in a higher LS Mean SKAMP-Combined Score compared to the placebo.*

FDA Label Image

Quillichew Er 4

NextWave Pharmaceuticals, Inc.*

FDA Label Image

Quillichew Er 5

NextWave Pharmaceuticals, Inc is a pharmaceutical company.*

FDA Label Image

Quillichew Er 6

This text provides instructions for storage, dispensing, dosage, and use of QuilliChew ER (methylphenidate hydrochloride) extended-release chewable tablets. The tablets contain 20 mg of methylphenidate hydrochloride and should be kept in a tightly closed, child-resistant container at a temperature ranging between 20°C and 25°C (68°F and 77°F). Furthermore, the tablets can be stored at temperatures between 15°C and 30°C (59°F and 86°F), as per USP Controlled Room Temperature regulations. The manufacturer, Tris Pharma, warns that the product contains phenylalanine and includes the NDC and GTIN codes for identification. The text also advises that the prescribing information should be consulted before use and to keep the medication out of reach of children.*

FDA Label Image

Quillichew Er 7

This is a medication guide for QuilliChew ER®, containing methylphenidate hydrochloride, manufactured by Tris Pharma, Inc. The medication is dispensed in child-resistant containers with 100 chewable tablets per bottle. The tablets are scored and each contains 30mg of methylphenidate hydrochloride. It is important to keep the medication out of reach of children and store it at controlled room temperature. The accompanying documents provide important information to patients and pharmacists.*

FDA Label Image

Quillichew Er 8

This text is related to a medication called QuilliChew ER® (methylphenidate HCI) extended-release chewable tablets. The tablets contain methylphenidate hydrochloride and are dispensed in tight, child-resistant containers. The dosage and use information is provided in the accompanying prescribing information. Each tablet contains 40 mg of methylphenidate hydrochloride and approximately 6 mg phenylalanine. The temperature range for storage is 68°F to 77°F with allowable excursions from 59°F to 86°F. Otherwise, the description of the product is not available.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.